Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TBPL1 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | ZHX1 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | CD74 | CCLE | pan-cancer | AAC | -0.37 | 1e-09 |
mRNA | CYTIP | GDSC1000 | pan-cancer | AAC | -0.31 | 1e-09 |
mRNA | ARRB1 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | RUBCNL | GDSC1000 | pan-cancer | AAC | -0.25 | 2e-09 |
mRNA | MPP1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | MYO18B | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | SAMSN1 | CCLE | pan-cancer | AAC | 0.41 | 2e-09 |
mRNA | PTGDR2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |